Fractal Analysis of the Pulmonary Arterial Tree in Pulmonary Hypertension
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators propose to confirm that normotensive and hypertensive pulmonary arteries are fractal, as well as define if the FD correlates to disease severity when compared to available data such as six-minute walk and right heart catheterization measurements.
| Condition | Intervention |
|---|---|
|
Pulmonary Hypertension |
Other: No Intervention |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Retrospective |
| Official Title: | Fractal Analysis of the Pulmonary Arterial Tree in Pulmonary Hypertension. |
- FD of the pulmonary artery in patients with PH will be lower when compared to patients without PH. [ Time Frame: 24 Months ] [ Designated as safety issue: No ]
- FD will correlate with the degree of PH as quantified by the MPAP obtained during RHC. [ Time Frame: 24 Months ] [ Designated as safety issue: No ]
- FD will correlate with the functional capacity of the PH patients as quantified by distance during six-minute walk and NYHA functional class. [ Time Frame: 24 Months ] [ Designated as safety issue: No ]
| Enrollment: | 6 |
| Study Start Date: | April 2010 |
| Study Completion Date: | February 2012 |
| Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Pulmonary Hypertension
Patients having a right heart catheterization and CT pulmonary angiogram with a diagnosis of Pulmonary Hypertension
|
Other: No Intervention
This study does not include an intervention but is observational in nature.
|
|
Non Pulmonary Hypertension
Patients having a right heart catheterization and CT pulmonary angiogram without a diagnosis of Pulmonary Hypertension.
|
Other: No Intervention
This study does not include an intervention but is observational in nature.
|
Detailed Description:
Pulmonary hypertension (PH) is an insidious disorder that can occur in isolation or as a result of various other pulmonary and systemic conditions. If left untreated PH may progress to right heart failure and death. Numerous tests are suggestive but not diagnostic of PH including cardiac echo, pulmonary function testing and chest x-ray. Definitive diagnosis requires right heart catheterization that is invasive, costly and time consuming. The fractal dimension (FD) is an index of the space-filling properties of an object so that the closer the dimension is to the topological dimension in which the object is embedded, the greater the space filling properties. No investigations have been performed to analyze the fractal dimension of pulmonary arteries in patients with PH. We propose to confirm that normotensive and hypertensive pulmonary arteries are fractal, as well as define if the FD correlates to disease severity when compared to available data such as six-minute walk and right heart catheterization measurements.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients having a right heart catheterization and CT pulmonary angiogram
Inclusion Criteria:
- Patients having a right heart catheterization and CT pulmonary angiogram
Exclusion Criteria:
- None
Contacts and Locations| United States, Ohio | |
| The Ohio State University Medical Center | |
| Columbus, Ohio, United States, 43210 | |
| Principal Investigator: | Karen Wood, M.D. | Ohio State University |
More Information
No publications provided
| Responsible Party: | Karen Wood, M.D., Ohio State University |
| ClinicalTrials.gov Identifier: | NCT01135706 History of Changes |
| Other Study ID Numbers: | 2010H0097 |
| Study First Received: | May 20, 2010 |
| Last Updated: | October 31, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Ohio State University:
|
Pulmonary Hypertension Fractal dimension |
Additional relevant MeSH terms:
|
Hypertension Hypertension, Pulmonary Vascular Diseases |
Cardiovascular Diseases Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 16, 2013